However, clinical research increasingly recognized that patients with metabolic diseases frequently experience clusters of systemic complications, including heart failure (HF), chronic kidney disease (CKD), and fatty liver disease, that single-target drugs historically failed to address comprehensively
These medications work by enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite
On the positive side, many report feeling increased energy and better blood sugar control, which can contribute to improved overall well-being
Available from: Accessed February 03, 2026
A potent antioxidant system may be present in the follicular fluid as indicated by low levels of all 3 biomarkers of oxidative stress in the follicular fluid
McClenaghan, N